NCT03966768

Brief Summary

This is a multisite randomized control proof-of-concept trial to evaluate the safety of Duramesh laparotomy closure in the trauma and emergency laparotomy setting. The study will be performed at University of Maryland Shock Trauma Center and Walter Reed National Military Medical Center. One hundred (100) patients will be randomized (2:1) to Duramesh laparotomy closure versus conventional suture closure. After the patient has been confirmed to be a candidate for the trial, randomization will be performed in the operating room upon completion of the index abdominal procedure. Duramesh will be provided for patients assigned to the Duramesh treatment arm. Patients will be followed for 1 year following laparotomy closure at follow-up intervals of 1 month, 3 months, 6 months, and 12 months.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 29, 2019

Completed
4.4 years until next milestone

Study Start

First participant enrolled

October 15, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 13, 2022

Status Verified

September 1, 2022

Enrollment Period

1.2 years

First QC Date

May 23, 2019

Last Update Submit

September 7, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Surgical site infection

    Superficial or deep infection of the surgical site

    1 month

  • Surgical site infection

    Superficial or deep infection of the surgical site

    3 months

  • Surgical site infection

    Superficial or deep infection of the surgical site

    6 months

  • Surgical site infection

    Superficial or deep infection of the surgical site

    12 months

Secondary Outcomes (16)

  • Surgical site occurrence

    1 month

  • Surgical site occurrence

    3 months

  • Surgical site occurrence

    6 months

  • Surgical site occurrence

    12 months

  • Intraoperative and hospitalization endpoints

    Within 30 days

  • +11 more secondary outcomes

Study Arms (3)

Duramesh suturable mesh for laparotomy closure

EXPERIMENTAL

Patients undergoing a midline laparotomy for trauma or emergency surgery will be closed with Duramesh suturable mesh.

Device: Duramesh suturable mesh for laparotomy closure

Conventional suture closure for laparotomy closure

EXPERIMENTAL

Patients randomized to conventional laparotomy closure will be closed using size 1 slowly-absorbing polydiaxonone (PDS) single strand or looped suture, based on surgeon preference.

Device: Conventional suture for laparotomy closure

Open abdomen group closed in delayed fashion with Duramesh

EXPERIMENTAL

Patients undergoing delayed primary closure of an open abdomen will also be studied. 20 study patients undergoing delayed primary closure of an open abdomen will be closed with Number 1 or Number 2 Duramesh

Device: Duramesh suturable mesh for laparotomy closure

Interventions

Patients undergoing laparotomy will be closed with Duramesh suturable mesh

Duramesh suturable mesh for laparotomy closureOpen abdomen group closed in delayed fashion with Duramesh

Patients undergoing laparotomy will be closed with conventional polydiaxonone suture

Conventional suture closure for laparotomy closure

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Midline laparotomy greater than 5 cm in length
  • Urgent or emergent surgery following trauma
  • Urgent or emergent surgery for diverticulitis
  • Large or small bowel obstruction, acute abdomen, or intra-abdominal hemorrhage.
  • Open abdomen after midline laparotomy.

You may not qualify if:

  • Prior hernia repair or existing abdominal mesh
  • Metastatic cancer
  • Pregnancy
  • Immunosuppression.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Dumanian GA, Lanier ST, Souza JM, Young MW, Mlodinow AS, Boller AM, Mueller KH, Halverson AL, McGee MF, Stulberg JJ. Mesh sutured repairs of contaminated incisional hernias. Am J Surg. 2018 Aug;216(2):267-273. doi: 10.1016/j.amjsurg.2017.10.025. Epub 2017 Oct 25.

    PMID: 29108644BACKGROUND
  • Lanier ST, Dumanian GA, Jordan SW, Miller KR, Ali NA, Stock SR. Mesh Sutured Repairs of Abdominal Wall Defects. Plast Reconstr Surg Glob Open. 2016 Sep 28;4(9):e1060. doi: 10.1097/GOX.0000000000001060. eCollection 2016 Sep.

    PMID: 27757361BACKGROUND
  • Dumanian GA, Tulaimat A, Dumanian ZP. Experimental study of the characteristics of a novel mesh suture. Br J Surg. 2015 Sep;102(10):1285-92. doi: 10.1002/bjs.9853. Epub 2015 Jul 8.

    PMID: 26154703BACKGROUND
  • Souza JM, Dumanian ZP, Gurjala AN, Dumanian GA. In vivo evaluation of a novel mesh suture design for abdominal wall closure. Plast Reconstr Surg. 2015 Feb;135(2):322e-330e. doi: 10.1097/PRS.0000000000000910.

    PMID: 25626817BACKGROUND

MeSH Terms

Conditions

Incisional Hernia

Condition Hierarchy (Ancestors)

HerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Officials

  • Jason M Souza, MD

    Walter Reed Army Institute of Research (WRAIR)

    PRINCIPAL INVESTIGATOR
  • Thomas Scalea, MD

    U Maryland Shock Trauma

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Clinical Trial
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2019

First Posted

May 29, 2019

Study Start

October 15, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

September 13, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

As per the sponsor wishes